# Sarkana Pharma, Inc.: Form D filing

Sarkana Pharma, Inc., a pharmaceuticals company in Wilmington, DE, filed a Form D with the SEC in 2021. The latest, on February 17, 2021, reports $1.6 million sold of an offering with no set size to 1 investor.

Find out what Sarkana Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Sarkana%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Sarkana%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsarkana-pharma-inc-1845313)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Sarkana%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Sarkana%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsarkana-pharma-inc-1845313)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Delaware](https://specstream.ai/data/form-d/state/delaware): 1,342 rows, by operating companies, filed since November 1, 2024, $67.10, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/delaware
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1000 N. WEST ST., SUITE 1200, Wilmington, DE, 19801
- Phone: (649) 332-4417
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2020
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1845313

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 17, 2021 | New notice | Indefinite | $1,579,000 | Indefinite | 1 | Dec 21, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1845313/000184531321000001/0001845313-21-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Caroline Fortier | Executive Officer |  |
| Luc Marengere | Director |  |
| Mark Cipriano | Executive Officer |  |

[Every Form D from the week of Feb 15, 2021](https://specstream.ai/data/form-d/week/2021-02-15) · [All recent filings in Delaware](https://specstream.ai/data/form-d/state/delaware) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Sarkana Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).